Almirall Extends Dermatology Reach With Dermira Lebrikizumab Deal

 
• By Sten Stovall

Almirall has re-affirmed its dermatology emphasis by entering a lebrikizumab option and license pact with Dermira for treating eczema in Europe.

Atopic dermatitis
Lebrikizumab is being tested in moderate-to-severe atopic dermatitis • Source: Shutterstock

More from Deals

More from Business